You have successfully logged out.

Hello !

Integrated Annual Report 2023

Empowered by Technology

Our fiscal year 2023 marks the end of the first phase of our strategic framework, B. Braun—the next decade. Over the past three years, we have worked hard to make new technologies available to the health care sector. This is how we are creating tangible progress—for our customers, and for improved patient care.

The fiscal year in numbers

B. Braun is one of the world’s leading medical technology companies. As a true partner, we develop smart solutions and set standards to improve health care. We utilize the latest technology to enhance the benefits of our core medical products with other products, services and digital systems. Our integrated solutions aim to make medical treatment more innovative, more efficient and more sustainable. 

Along with our strategy, we continue to grow our business in 2023 again in a demanding environment. B. Braun sales grew 6.5 percent at constant exchange rates. We maintained our long-term growth strategy and met our strategic target corridor of 5 to 7 percent. Sales in the reporting currency increased 3.0 percent to € 8.8 billion (previous year: € 8.5 billion). Profit before taxes improved 15.3 percent. This proves that we have the experience and skills to navigate through volatile times. 


 20222023Change in %
Sales (in € million)8,499.88,755.0+ 3.0
EBITDA (in € million)997.21,019.4+ 2.2
Profit before taxes (in € million)178.7206.0+ 15.3

Employees (as of December 31)

65,05563,011- 3.1


Related Topics

Discover similar topics from B. Braun